Navigation Links
WuXi PharmaTech Announces First Quarter 2008 Results
Date:5/27/2008

11,284 921

Land use rights, net 5,333 5,160

Other non-current assets 4,309 2,183

Total non-current assets 260,871 81,898

Total assets 408,292 343,775

Liabilities and shareholders' equity:

Current liabilities:

Short-term bank borrowings, current 7,830 --

Accounts payable 14,017 7,216

Accrued expenses 13,262 12,279

Deferred revenue 13,215 19,706

Advanced subsidies 2,074 1,077

Other taxes payable 4,039 4,060

Other current liabilities 3,432 1,233

Total current liabilities 57,869 45,571

Non-current liabilities:

Long-term debt, excluding current portion 10,588 4,108

Advanced subsidies 2,339 1,529

Convertible notes 35,864 40,988

Deferred tax liabilities (Note 1) 3,897 181

Other non-current liabilities 2,980 --

Total non-current liabilities 55,668 46,806

Total liabilities 113,537 92,377

Shareholders' equity:

Ordinary shares (Note 2), ($0.02 par

value, 5,002,550,000 authorized

492,226,776 and 499,600,302 issued

and outstanding as of December 31,

2007 and March 31, 2008, respectively) 9,992 9,845

Additional paid-in capital 314,146 291,020

Accumu
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
2. WuXi PharmaTech Announces Second Quarter 2007 Results
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
11. WuXi PharmaTech Completes Acquisition of AppTec
Post Your Comments:
*Name:
*Comment:
*Email: